Investor Relations

Stock price graph

GenMark Dx's mission is to become the market leader in providing high value, simple to perform, clinically relevant multiplex molecular tests to aid in the diagnosis of disease and the selection and dosing of therapies.

For investor information, please contact IR@genmarkdx.com.

Annual Reports

2014 Proxy Statement

2013 Annual Report

2013 Proxy Statement

2012 Annual Report

2011 Annual Report

2012 Proxy Statement


Recent Releases

Oct 17, 2014
GenMark Diagnostics Schedules Third Quarter 2014 Financial Results Conference Call for October 30, 2014

Aug 11, 2014
GenMark Diagnostics Reports Second Quarter 2014 Results

View all releases »

Events

Oct 30, 2014 at 4:30 PM ET
GenMark Diagnostics Third Quarter Earnings Conference Call

View all events »

Related Links

Stock Quote
Price:
9.66
Change:
+ 0.14
Day High:
9.72
Day Low:
9.36
Volume:
222,800
NASDAQ
GNMK
4:00 PM ET on Oct 24, 2014
Delayed at least 20 minutes.
Provided by eSignal.